Back to search results

Preventing Type 2 Diabetes After Gestational Diabetes with Immediate Postpartum Screening

This study is looking at a new way to screen for Type 2 Diabetes (T2DM) in women who had gestational diabetes (GDM) during pregnancy. Currently, many women don't attend their recommended postpartum diabetes screening. This study will test if doing a 2-hour glucose tolerance test (a diagnostic test for diabetes) right after delivery, while you are still in the hospital, can help more women get screened. Some participants will receive this early testing, while others will receive standard care, which includes educational materials about healthy living and diabetes risks. The main goals are to see if early screening helps detect T2DM and to check blood sugar levels (Hemoglobin A1c). You might be able to join if you had GDM, are delivering at UMASS Memorial, and can have the in-hospital glucose testing.

Study design
This is an interventional study with a planned enrollment of 116 women. Participants will be randomized to either receive early glucose tolerance testing or standard care.
What's involved
Participants will either have a 2-hour glucose tolerance test during their postpartum hospitalization or receive educational materials. Blood sugar levels will be measured at the time of postpartum screening.
Compensation
Not stated in the trial record.
Follow-up
Detection of Type 2 Diabetes Mellitus and Glycemic Outcomes will be measured at the time of postpartum screening (postpartum day 1 or 6-week postpartum visit depending on the group you are in).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06457139

Preventing T2DM After GDM With Immediate Postpartum Screening

Completed
NAAges 18+InterventionalScreening
University of Massachusetts, Worcester
~116 participants
Updated 2026-08-14 on ClinicalTrials.gov
What's tested:Glucose tolerance test (2 hour)Active Comparator

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Detection of Type 2 Diabetes Mellitus
Measured over At time of postpartum screening (postpartum day 1 or 6 week postpartum visit pending randomization arm)
+1 more outcome measured

Conditions

Gestational Diabetes
Type 2 Diabetes

Explore related trials

Gestational Diabetes

Where it's being run

1 sites across 1 states
Massachusetts1

Study leadership

  • Gianna Wilkie, MD · PRINCIPAL_INVESTIGATOR · UMASS Memorial Healthcare

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria
receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial
able and willing to provide informed consent
ability to complete immediate in hospital postpartum glucose testing
have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg/dL or 2-hour glucose value of ≥200 mg/dL

Exclusion

known diagnosis of pre-existing pre-gestational diabetes in pregnancy
inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum
systemic steroid use

What this trial measures

  • Detection of Type 2 Diabetes MellitusAt time of postpartum screening (postpartum day 1 or 6 week postpartum visit pending randomization arm)

    Detection of Type 2 Diabetes Mellitus by 2 hour oral glucose tolerance test

  • Glycemic Outcomes--Hemoglobin A1cat time of postpartum screening (postpartum day 1 or 6 week postpartum visit pending randomization arm)

    Serum blood measurement of hemoglobin A1c